Comments

Pasithea Therapeutics

Q: What sector and industry does Pasithea Therapeutics (KTTAW) operate in?

Pasithea Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

KTTAWNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$0.0202

At close: Nov 20, 8:03 AM EDT

$0.0400

0.0298.02%

After Hours: Nov 20, 8:03 AM EDT

Pasithea Therapeutics (KTTAW) Forecast

News Earnings Pasithea Therapeutics (KTTAW) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Pasithea Therapeutics (NASDAQ:KTTAW) Stock Quotes, Forecast and News Summary

Pasithea Therapeutics Stock (NASDAQ: KTTAW) stock price, news, charts, stock research, profile.

Open	-
Close	-
Volume / Avg.	0 / 17.13K
Day Range	- - -
52 Wk Range	0.00 - 0.10
Market Cap	-
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	0
Short Interest	-
Days to Cover	1

Recent News

No news found

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Open	-
Close	-
Volume / Avg.	0 / 17.13K
Day Range	- - -
52 Wk Range	0.00 - 0.10
Market Cap	-
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	0
Short Interest	-
Days to Cover	1

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Pasithea Therapeutics (KTTAW) stock?

You can purchase shares of Pasithea Therapeutics (NASDAQ:KTTAW) through any online brokerage.

View our list of the best stock brokerages

Who are Pasithea Therapeutics (KTTAW) competitors?

Other companies in Pasithea Therapeutics’s space includes: Sarepta Therapeutics (NASDAQ:SRPT), Exact Sciences (NASDAQ:EXAS), Neurocrine Biosciences (NASDAQ:NBIX), Roivant Sciences (NASDAQ:ROIV) and Amgen (NASDAQ:AMGN).

What is the forecast, or price target, for Pasithea Therapeutics (KTTAW) stock?

There is no analysis for Pasithea Therapeutics to provide a consensus price target.

What is the current price for Pasithea Therapeutics (KTTAW)?

The stock price for Pasithea Therapeutics (NASDAQ: KTTAW) is $0.04 last updated November 20, 2024 at 8:03 AM EST.

Does Pasithea Therapeutics (KTTAW) pay a dividend?

There are no upcoming dividends for Pasithea Therapeutics.

When is Pasithea Therapeutics (NASDAQ:KTTAW) reporting earnings?

Pasithea Therapeutics does not have any upcoming earnings scheduled.

Is Pasithea Therapeutics (KTTAW) going to split?

There is no upcoming split for Pasithea Therapeutics.

What sector and industry does Pasithea Therapeutics (KTTAW) operate in?

Pasithea Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.